Evaluating Mucosal and Systemic Immunity in an Observational Cohort of South African Children Hospitalised with Acute Respiratory Tract Infections.

Publication date: Jun 20, 2026

Acute respiratory infections, including SARS-CoV-2, remain a leading cause of childhood morbidity and mortality in low- and middle-income countries (LMICs), yet the underlying immune determinants of disease severity are poorly understood. The increased susceptibility to SARS-CoV-2 could be related to a decreased antibody or altered inflammatory response. We conducted a cohort study of South African children hospitalised with acute respiratory infections, and collected mucosal and serum samples over time. Nasopharyngeal aspirates (NPAs) or swabs were tested for viral pathogens by multiplex PCR. Antibody levels, neutralising capacity, and inflammatory proteome profiles were assessed. In the cohort (median age 7. 31 months, IQR 2. 9-31. 7), 67 children (54%) were SARS-CoV-2 positive at enrolment. Substantial baseline anti-spike IgG was detected in both SARS-CoV-2-positive (68% serum, 58% saliva) and negative (40% serum, 36% saliva) patients, irrespective of disease severity. Lower expression of salivary inflammatory proteins was associated with severe disease (p

Concepts Keywords
African Acute
Biomarkers African
Hospitalised Antibody
Months Cohort
Viral Cov
Hospitalised
Infections
Inflammatory
Lmics
Mucosal
Respiratory
Sars
Serum
Severity
South

Semantics

Type Source Name
disease MESH Respiratory Tract Infections

Original Article

(Visited 7 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *